VBS.AX
Price:
$0.11
Market Cap:
$5.87M
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. ...[Read more]
Industry
Biotechnology
IPO Date
2016-02-22
Stock Exchange
ASX
Ticker
VBS.AX
According to Vectus Biosystems Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 5.82M. This represents a change of 2.97% compared to the average of 5.65M of the last 4 quarters.
The mean historical Enterprise Value of Vectus Biosystems Limited over the last ten years is 21.67M. The current 5.82M Enterprise Value has changed 2.58% with respect to the historical average. Over the past ten years (40 quarters), VBS.AX's Enterprise Value was at its highest in in the December 2021 quarter at 50.02M. The Enterprise Value was at its lowest in in the December 2011 quarter at 0.
Average
21.67M
Median
21.64M
Minimum
2.08M
Maximum
40.94M
Discovering the peaks and valleys of Vectus Biosystems Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 173.68%
Maximum Annual Enterprise Value = 40.94M
Minimum Annual Increase = -82.09%
Minimum Annual Enterprise Value = 2.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.08M | -36.34% |
| 2024 | 3.26M | -82.09% |
| 2023 | 18.22M | -52.68% |
| 2022 | 38.50M | -5.96% |
| 2021 | 40.94M | 81.61% |
| 2020 | 22.54M | 128.33% |
| 2019 | 9.87M | -52.40% |
| 2018 | 20.74M | -35.57% |
| 2017 | 32.19M | 13.49% |
| 2016 | 28.36M | 173.68% |
The current Enterprise Value of Vectus Biosystems Limited (VBS.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.85M
5-year avg
20.60M
10-year avg
21.67M
Vectus Biosystems Limited’s Enterprise Value is less than Bio-Gene Technology Limited (6.84M), greater than Invex Therapeutics Ltd (3.64M), less than Adherium Limited (10.78M), greater than Biotron Limited (4.05M), less than Acrux Limited (9.34M), less than Cann Group Limited (81.46M), less than Invion Limited (7.37M), greater than InhaleRx Limited (5.34M), less than HITIQ Limited (17.35M), less than Memphasys Limited (14.63M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 6.84M | $7.93M | |
| 3.64M | $9.02M | |
| 10.78M | $7.71M | |
| 4.05M | $4.98M | |
| 9.34M | $6.57M | |
| 81.46M | $5.63M | |
| 7.37M | $8.22M | |
| 5.34M | $5.49M | |
| 17.35M | $12.67M | |
| 14.63M | $9.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectus Biosystems Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vectus Biosystems Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vectus Biosystems Limited's Enterprise Value?
What is the highest Enterprise Value for Vectus Biosystems Limited (VBS.AX)?
What is the 3-year average Enterprise Value for Vectus Biosystems Limited (VBS.AX)?
What is the 5-year average Enterprise Value for Vectus Biosystems Limited (VBS.AX)?
How does the current Enterprise Value for Vectus Biosystems Limited (VBS.AX) compare to its historical average?